Vivo Capital, LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 66 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2020$4,396,000
-30.7%
145,417
-3.3%
0.25%
-44.2%
Q2 2020$6,339,000
+0.8%
150,349
-40.4%
0.46%
-20.2%
Q1 2020$6,290,000252,1190.57%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q1 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$86,074,0004.50%
Boxer Capital, LLC 2,014,858$50,271,0003.43%
RA Capital Management 2,589,904$64,618,0002.04%
Artal Group S.A. 1,696,517$42,328,0001.79%
Logos Global Management LP 123,465$2,772,0001.05%
BVF INC/IL 378,788$9,451,0000.88%
Casdin Capital, LLC 289,395$7,220,0000.77%
Perceptive Advisors 1,104,656$27,561,0000.72%
Bellevue Group AG 1,330,000$33,184,0000.64%
Vivo Capital, LLC 252,119$6,290,0000.57%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders